Related Experiment Videos
The "phantom" optic nerve. Demonstration in CT and MR scans 19 years after resection of optic glioma
M C Brodsky1, W F Hoyt, D R Newton
1Neuro-ophthalmology Unit, University of California, San Francisco.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Lyme neuroborreliosis: a treatable cause of acute ocular motor disturbances in children.
The British journal of ophthalmology·2015
Complete resolution of hypertension after decompression of Chiari I malformation.
Skull base surgery·2006
When is isolated inferior oblique muscle surgery an appropriate treatment for superior oblique palsy?
European journal of ophthalmology·2006
Intermittent exotropia increasing with near fixation: a "soft" sign of neurological disease.
The British journal of ophthalmology·2005
Intermittent exotropia increasing with near fixation: a "soft" sign of neurological disease.
The British journal of ophthalmology·2005
Optic disc duplication or coloboma?
The British journal of ophthalmology·2004
Digoxin toxicity. Recognizing the varied visual presentations.
Journal of clinical neuro-ophthalmology·1993
Duane's syndrome with giant aneurysm of the vertebral basilar arterial junction.
Journal of clinical neuro-ophthalmology·1993
Recovery of vision in a 47-year-old man with fulminant giant cell arteritis.
Journal of clinical neuro-ophthalmology·1993
Botulinum toxin type A in upper lid retraction of Graves' ophthalmopathy.
Journal of clinical neuro-ophthalmology·1993
Iron mydriasis. Pupillary paresis from occult intraocular foreign body.
Journal of clinical neuro-ophthalmology·1993
Herpes zoster ophthalmicus as a cause of Horner syndrome.
Journal of clinical neuro-ophthalmology·1993
Unilateral nonarteritic anterior ischemic optic neuropathy associated with obstructive sleep apnea-hypopnea syndrome: a case report.
Journal of medical case reports·2026
Application of nanozyme-based drug delivery systems in the treatment of ROS-related ophthalmic diseases.
International journal of pharmaceutics: X·2026
Nano formulations of quercetin for ocular delivery.
BioImpacts : BI·2026